Operating Income (Loss) in USD of ASPEN AEROGELS INC from 2012 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Aspen Aerogels Inc quarterly/annual Operating Income (Loss) history and growth rate from 2012 to Q3 2025.
  • Aspen Aerogels Inc Operating Income (Loss) for the quarter ending September 30, 2025 was -$3.35M, a 119% decline year-over-year.
  • Aspen Aerogels Inc Operating Income (Loss) for the twelve months ending September 30, 2025 was -$293M, a 811% decline year-over-year.
  • Aspen Aerogels Inc annual Operating Income (Loss) for 2024 was $54.5M.
  • Aspen Aerogels Inc annual Operating Income (Loss) for 2023 was -$49.2M, a 37.9% increase from 2022.
  • Aspen Aerogels Inc annual Operating Income (Loss) for 2022 was -$79.2M, a 95.2% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)

ASPEN AEROGELS INC Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$293M -$3.35M -$20.7M -119% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-06
Q2 2025 -$272M -$5.16M -$25.1M -126% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 -$247M -$299M -$302M -12388% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $54.5M $14.7M +$13.3M +964% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 $41.2M $17.4M +$32M Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-06
Q2 2024 $9.17M $20M +$37M Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 -$27.9M $2.44M +$21.3M Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q4 2023 -$49.2M $1.38M +$11M Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 -$60.3M -$14.6M +$13.7M +48.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$73.9M -$17M +$5.6M +24.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$79.5M -$18.9M -$284K -1.53% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 -$79.2M -$9.67M +$6.65M +40.7% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-27
Q3 2022 -$85.9M -$28.3M -$16.8M -146% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$69.1M -$22.6M -$16M -242% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$53M -$18.6M -$12.4M -202% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$40.6M -$16.3M -$10.2M -166% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-07
Q3 2021 -$30.4M -$11.5M -$4.79M -71.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$25.6M -$6.61M -$966K -17.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$24.7M -$6.18M -$3.09M -100% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$21.6M -$6.13M -$5.3M -639% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-12
Q3 2020 -$16.3M -$6.7M -$4.55M -211% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$11.7M -$5.65M -$433K -8.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 -$11.3M -$3.09M +$2.88M +48.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 -$14.2M -$830K +$13.1M +94% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-12
Q3 2019 -$27.3M -$2.15M +$4.22M +66.2% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-12
Q2 2019 -$31.5M -$5.22M +$1.64M +23.9% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-12
Q1 2019 -$33.1M -$5.96M +$789K +11.7% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-12
Q4 2018 -$33.9M -$13.9M -$12.3M -760% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-06
Q3 2018 -$21.6M -$6.37M -$3.34M -110% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-06
Q2 2018 -$18.3M -$6.86M -$1.42M -26.2% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-06
Q1 2018 -$16.8M -$6.75M +$2.3M +25.4% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-06
Q4 2017 -$19.1M -$1.62M +$4.09M +71.6% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-08
Q3 2017 -$23.2M -$3.03M -$626K -26% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-08
Q2 2017 -$22.6M -$5.43M -$4.09M -303% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-08
Q1 2017 -$18.5M -$9.05M -$7.29M -415% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-08
Q4 2016 -$11.2M -$5.71M -$7.39M -439% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 -$3.83M -$2.4M +$72K +2.91% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-01
Q2 2016 -$3.9M -$1.35M +$1.34M +49.9% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-01
Q1 2016 -$5.24M -$1.76M +$987K +36% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-01
Q4 2015 -$6.23M $1.68M +$4.34M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-02
Q3 2015 -$10.6M -$2.48M -$111K -4.69% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-02
Q2 2015 -$10.5M -$2.69M +$5.43M +66.9% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-02
Q1 2015 -$15.9M -$2.75M +$153K +5.28% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-02
Q4 2014 -$16M -$2.66M +$3.99M +60% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-04
Q3 2014 -$20M -$2.37M +$2.3M +49.3% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-04
Q2 2014 -$22.3M -$8.12M -$5.48M -208% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-04
Q1 2014 -$16.8M -$2.9M +$3.13M +51.9% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-04
Q4 2013 -$20M -$6.64M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-13
Q3 2013 -$4.67M Jul 1, 2013 Sep 30, 2013 10-K 2015-03-13
Q2 2013 -$2.64M Apr 1, 2013 Jun 30, 2013 10-K 2015-03-13
Q1 2013 -$6.03M Jan 1, 2013 Mar 31, 2013 10-K 2015-03-13

ASPEN AEROGELS INC Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $54.5M +$104M Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 -$49.2M +$30M +37.9% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 -$79.2M -$38.6M -95.2% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 -$40.6M -$19M -88.2% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-07
2020 -$21.6M -$7.41M -52.3% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-16
2019 -$14.2M +$19.8M +58.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 -$33.9M -$14.8M -77.2% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-12
2017 -$19.1M -$7.92M -70.6% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-06
2016 -$11.2M -$4.99M -80% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-08
2015 -$6.24M +$9.81M +61.1% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 -$16M +$3.93M +19.7% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-02
2013 -$20M +$13M +39.4% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-04
2012 -$33M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.